Joe Ciaffoni
About Joe Ciaffoni
Joe Ciaffoni is the President and CEO of Collegium Pharmaceutical, having been appointed in July 2018 after joining the company in May 2017 as Executive Vice President and Chief Operating Officer.
Joe Ciaffoni Collegium Pharmaceutical
Joe Ciaffoni was appointed as the President and Chief Executive Officer of Collegium Pharmaceutical in July 2018. He joined the company in May 2017, initially serving as the Executive Vice President and Chief Operating Officer. In his current role, Ciaffoni oversees all aspects of Collegium's operations and strategic initiatives.
Joe Ciaffoni Endo International plc
Before joining Collegium Pharmaceutical, Joe Ciaffoni served as the President of U.S. Branded Pharmaceuticals at Endo International plc. In this position, he was responsible for overseeing the commercial strategy and operations of the company's branded pharmaceutical products in the United States.
Joe Ciaffoni Professional Background
Joe Ciaffoni held various significant roles before his tenure at Collegium Pharmaceutical. At Biogen, he was the Senior Vice President of the Global Specialty Medicines Group and the Senior Vice President of U.S. Commercial. He also served as Executive Vice President and Chief Operating Officer of Shionogi Inc. and President of Shionogi Pharmaceuticals. Additionally, he was Vice President of Sales for Schering-Plough (now Merck) and held several commercial leadership roles at Sanofi-Synthelabo (now Sanofi) and Novartis.
Joe Ciaffoni Education and Credentials
Joe Ciaffoni holds a Bachelor of Arts in Communications and a Master of Business Administration from Rutgers University. His academic background and comprehensive industry experience have equipped him with the skills necessary for his leadership roles in the pharmaceutical sector.